The Pfizer / BioNTech vaccine against covid-19 is fully effective among young people ages 12 to 15, both companies announced Wednesday.
These results correspond to phase 3 of a clinical trial in which more than 2,200 young people of that age range participated.
READ MORE: All 50 US states expanded or will extend eligibility to get the Covid-19 vaccine to everyone 16 and older